- Home
- QNCX vs SRTS Comparison
QNCX vs SRTS Comparison
Compare QNCX & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- SRTS
- Stock Information
- Founded
- QNCX 2012
- SRTS 2010
- Country
- QNCX United States
- SRTS United States
- Employees
- QNCX N/A
- SRTS N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- SRTS Medical/Dental Instruments
- Sector
- QNCX Health Care
- SRTS Health Care
- Exchange
- QNCX Nasdaq
- SRTS Nasdaq
- Market Cap
- QNCX 92.3M
- SRTS 110.3M
- IPO Year
- QNCX 2019
- SRTS 2016
- Fundamental
- Price
- QNCX $1.60
- SRTS $6.92
- Analyst Decision
- QNCX Strong Buy
- SRTS Strong Buy
- Analyst Count
- QNCX 4
- SRTS 2
- Target Price
- QNCX $9.50
- SRTS $12.50
- AVG Volume (30 Days)
- QNCX 147.1K
- SRTS 209.3K
- Earning Date
- QNCX 11-13-2024
- SRTS 02-05-2025
- Dividend Yield
- QNCX N/A
- SRTS N/A
- EPS Growth
- QNCX N/A
- SRTS N/A
- EPS
- QNCX N/A
- SRTS 0.57
- Revenue
- QNCX N/A
- SRTS $41,308,000.00
- Revenue This Year
- QNCX N/A
- SRTS $65.04
- Revenue Next Year
- QNCX N/A
- SRTS $24.87
- P/E Ratio
- QNCX N/A
- SRTS $12.16
- Revenue Growth
- QNCX N/A
- SRTS 65.62
- 52 Week Low
- QNCX $0.51
- SRTS $2.91
- 52 Week High
- QNCX $2.45
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- QNCX 42.75
- SRTS 46.56
- Support Level
- QNCX $1.40
- SRTS $6.69
- Resistance Level
- QNCX $1.79
- SRTS $7.26
- Average True Range (ATR)
- QNCX 0.15
- SRTS 0.34
- MACD
- QNCX -0.02
- SRTS 0.06
- Stochastic Oscillator
- QNCX 32.79
- SRTS 51.67
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.